Tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total community benefits in 2022. According to ...

Rather than using their federal 340B drug discount savings to lower costs for patients, many hospitals reinvest their profits into acquiring independent clinics.

In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...

The nation's top pharmaceutical trade group is taking a legal swing at Rhode Island's new drug-pricing law.

That's why we need Senate Bill 41, authored by Sen. Scott Wiener, D-San Francisco, which will require a more fair and ...

The 340B Drug Pricing Program was created to benefit low-income and uninsured Americans. Over time, it has morphed into a federal subsidy for hospitals in affluent areas at the expense ...

The 340B program, enacted by Congress in 1992, requires pharmaceutical companies to sell medications to rural hospitals at ...

In victory for struggling medical providers, law protecting a federal drug discount program in RI goes into effect despite ...

However, unlike Wall Street executives who begged Uncle Sam to cover their risky bets, cash-strapped nonprofit rural health ...

In Oklahoma, three Planned Parenthood health centers are listed as participating in the 340B program as family planning clinics.

Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need.

The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a ...